Publications by authors named "Luc Peeters"

Claim this Profile
S
Stabilization of Hybrid Adhesives and Sealants by Thermodynamic Tuning of Molecularly Optimized Lignin Bio-Additives: Small Changes, Big Effects.
Florence Isnard, Mikael Monga Mulunda, Maarten Rubens, Hanne Mariën, Tatsuro Harumashi, Luc Peeters

Biomacromolecules· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relating the Diers formetric measurements with the subjective severity of acute and chronic low back pain.
Inge Roman, Michiel Luyten, Hendrik Croonenborghs, Grégoire Lason, Luc Peeters

Med Hypotheses· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Covalent Allosteric Probe for the Metabotropic Glutamate Receptor 2: Design, Synthesis, and Pharmacological Characterization.
Maarten L J Doornbos, Xuesong Wang, Sophie C Vermond, Luc Peeters, Laura Pérez-Benito

J Med Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Switches of Allosteric Modulation of the Metabotropic Glutamate 2 Receptor.
Laura Pérez-Benito, Maarten L J Doornbos, Arnau Cordomí, Luc Peeters, Hilde Lavreysen

Structure· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM).
Jose María Cid, Gary Tresadern, Juan Antonio Vega, Ana Isabel de Lucas, Alcira Del Cerro, Luc Peeters

J Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterization of JNJ-40068782, a new potent, selective, and systemically active positive allosteric modulator of the mGlu2 receptor and its radioligand [3H]JNJ-40068782.
Hilde Lavreysen, Xavier Langlois, Abdel Ahnaou, Wilhelmus Drinkenburg, Paula te Riele, Luc Peeters

J Pharmacol Exp Ther· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of JNJ-37822681, a specific and fast-dissociating D2 antagonist for the treatment of schizophrenia.
Xavier Langlois, Anton Megens, Hilde Lavreysen, John Atack, Miroslav Cik, Luc Peeters

J Pharmacol Exp Ther· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of 2-[[4-fluoro-3-(trifluoromethyl)phenyl]amino]-4-(4-pyridinyl)-5-thiazolemethanol (JNJ-1930942), a novel positive allosteric modulator of the {alpha}7 nicotinic acetylcholine receptor.
Theo Dinklo, Hamdy Shaban, Jan Willem Thuring, Hilde Lavreysen, Karen E Stevens, Luc Peeters

J Pharmacol Exp Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis